BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21476883)

  • 1. Targeting mitotic exit for cancer treatment.
    Wäsch R
    Expert Opin Ther Targets; 2011 Jul; 15(7):785-8. PubMed ID: 21476883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy.
    Giovinazzi S; Bellapu D; Morozov VM; Ishov AM
    Cell Cycle; 2013 Aug; 12(16):2598-607. PubMed ID: 23907120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APC/C-Cdh1-dependent anaphase and telophase progression during mitotic slippage.
    Toda K; Naito K; Mase S; Ueno M; Uritani M; Yamamoto A; Ushimaru T
    Cell Div; 2012 Feb; 7():4. PubMed ID: 22321970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boosting the apoptotic response of high-grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.
    Raab M; Kobayashi NF; Becker S; Kurunci-Csacsko E; Krämer A; Strebhardt K; Sanhaji M
    Int J Cancer; 2020 Feb; 146(4):1086-1098. PubMed ID: 31286496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound.
    Jiang JD; Wang Y; Roboz J; Strauchen J; Holland JF; Bekesi JG
    Cancer Res; 1998 May; 58(10):2126-33. PubMed ID: 9605756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the anaphase promoting complex: common pathways for viral infection and cancer therapy.
    Smolders L; Teodoro JG
    Expert Opin Ther Targets; 2011 Jun; 15(6):767-80. PubMed ID: 21375465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution.
    Henriques AC; Ribeiro D; Pedrosa J; Sarmento B; Silva PMA; Bousbaa H
    Cancer Lett; 2019 Jan; 440-441():64-81. PubMed ID: 30312726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KRIBB3, a novel microtubule inhibitor, induces mitotic arrest and apoptosis in human cancer cells.
    Shin KD; Yoon YJ; Kang YR; Son KH; Kim HM; Kwon BM; Han DC
    Biochem Pharmacol; 2008 Jan; 75(2):383-94. PubMed ID: 17915194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy.
    Vogel C; Kienitz A; Hofmann I; Müller R; Bastians H
    Oncogene; 2004 Sep; 23(41):6845-53. PubMed ID: 15286707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mad2 is required for inhibiting securin and cyclin B degradation following spindle depolymerisation in meiosis I mouse oocytes.
    Homer HA; McDougall A; Levasseur M; Murdoch AP; Herbert M
    Reproduction; 2005 Dec; 130(6):829-43. PubMed ID: 16322543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs.
    Visconti R; Della Monica R; Palazzo L; D'Alessio F; Raia M; Improta S; Villa MR; Del Vecchio L; Grieco D
    Cell Death Differ; 2015 Sep; 22(9):1551-60. PubMed ID: 25744022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint.
    Magnaghi-Jaulin L; Eot-Houllier G; Fulcrand G; Jaulin C
    Cancer Res; 2007 Jul; 67(13):6360-7. PubMed ID: 17616695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitotic slippage: an old tale with a new twist.
    Sinha D; Duijf PHG; Khanna KK
    Cell Cycle; 2019 Jan; 18(1):7-15. PubMed ID: 30601084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors induce mitotic slippage.
    Stevens FE; Beamish H; Warrener R; Gabrielli B
    Oncogene; 2008 Feb; 27(10):1345-54. PubMed ID: 17828304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Budding Yeast to Identify Molecules That Block Cancer Cell 'Mitotic Slippage' Only in the Presence of Mitotic Poisons.
    Schuyler SC; Chen HY
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weakened APC/C activity at mitotic exit drives cancer vulnerability to KIF18A inhibition.
    Gliech CR; Yeow ZY; Tapias-Gomez D; Yang Y; Huang Z; Tijhuis AE; Spierings DC; Foijer F; Chung G; Tamayo N; Bahrami-Nejad Z; Collins P; Nguyen TT; Plata Stapper A; Hughes PE; Payton M; Holland AJ
    EMBO J; 2024 Mar; 43(5):666-694. PubMed ID: 38279026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mcl-1 dynamics influence mitotic slippage and death in mitosis.
    Sloss O; Topham C; Diez M; Taylor S
    Oncotarget; 2016 Feb; 7(5):5176-92. PubMed ID: 26769847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis.
    Lee SJ; Langhans SA
    BMC Cancer; 2012 Jan; 12():44. PubMed ID: 22280307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting mitosis exit: A brake for cancer cell proliferation.
    Liu X; Chen Y; Li Y; Petersen RB; Huang K
    Biochim Biophys Acta Rev Cancer; 2019 Jan; 1871(1):179-191. PubMed ID: 30611728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells.
    Yamada C; Morooka A; Miyazaki S; Nagai M; Mase S; Iemura K; Tasnin MN; Takuma T; Nakamura S; Morshed S; Koike N; Mostofa MG; Rahman MA; Sharmin T; Katsuta H; Ohara K; Tanaka K; Ushimaru T
    iScience; 2022 Feb; 25(2):103675. PubMed ID: 35141499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.